Cannara Biotech (CNBTF) Stock Price, News & Analysis

Company Overview

Cannara Biotech Inc. (OTCMKTS:CNBTF) is a Canadian cannabis company focused on the cultivation, processing and sale of indoor-grown cannabis and cannabis products. The company operates as a vertically integrated business, managing activities across cultivation, manufacturing, product development and distribution.

Cannara produces a range of cannabis offerings, including dried flower, pre-rolls, cannabis concentrates, hash, vaporizers and other cannabis-derived products. Its portfolio includes brands such as Tribal, Nugz and Orchid CBD, which are marketed through Canada’s regulated cannabis channels.

The company is based in Quebec and serves the Canadian cannabis market. Cannara’s operations include large-scale indoor cultivation and processing facilities in the province, supporting the production of cannabis products intended for both recreational and medical consumers.

Key Stats

• Today's Range: $1.49 to $1.56
• 50-Day Range: $1.31 to $1.51
• 52-Week Range: $0.08 to $0.20
• Volume: 57,000 shs
• Average Volume: 33,127 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CNBTF
• CIK: N/A
• Web: cannara.ca
• Phone: N/A
• Fax: N/A
• Employees: 13
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A